Back

McKesson Corporation

Ticker: MCK ISIN: US58155Q1031
Add to portfolio Portfolio analysis in 2min
Stock Large-cap Dividend payer Trading above 200-day average
Market cap
$100.76B
P/E
23.75
Forward P/E
18.87
Profit margin
1.09%
Revenue growth QoQ
11.40%
Div. yield
0.37%
Beta
0.42
$858.90 2.40%
Price as of 2026-08-21 · NYSE

Performance by timeframe

Rolling returns
1 Month +2.14%
6 Months -9.34%
1 Year +27.03%
5 Years +34.54% p.a.+340.33%
10 Years +17.61% p.a.+405.83%
Since inception +13.98% p.a.+2,529.17%
Calendar year returns
YTD +4.91%
2025 +44.54%
2024 +23.67%
2023 +24.13%
2022 +51.83%
2021 +44.23%

Key stats

Market cap
100.76B
P/E
23.75
Dividend yield
0.37%
Beta
0.42
52-week range
635.12 - 999.00
50-day MA
898.67
200-day MA
811.75
Section 1

Business overview

Company profile data from fundamentals.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Sector Healthcare
Industry Medical Distribution
Country United States
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 0.00%
ROA 4.33%
Profit margin 1.09%
Operating margin 1.55%
PEG ratio 1.02
Revenue/share TTM 3,202.88
Revenue TTM 397.96B
EBITDA 5.93B
Gross profit TTM 13.74B
Beta 0.42

Valuation

Trailing P/E 23.75
Forward P/E 18.87
P/B 5.04
P/S 0.25
EV/EBITDA 16.59
EV/Revenue 0.27

ESG Scores

Total ESG 23.8
Environment 9.1
Social 17.1
Governance 12.5
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 39.01
Quarterly earnings growth 38.00%
Revenue TTM 397.96B
Reported quarters 118
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 0.37%
Forward annual div. yield 0.43%
Dividend per share 3.0600
Payout ratio 9.43%
Ex-dividend date 2025-03-03
Next dividend date 2026-07-01
Split factor 2:1
Last split date 1998-01-05
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $650.48
Analyst rating 4.3529

Ownership & short interest

Shares outstanding 125.33M
Shares float 125.09M
Institutional ownership 89.82%
Insider ownership 7.50%
Short ratio 3.34
Short % of float 2.11%

Details

Instrument metadata and source update timestamps.

Symbol MCK
Name McKesson Corporation
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US58155Q1031
Country USA
Code + exchange MCK.NYSE
Last price date 2026-04-29
Fundamentals updated 2026-04-30

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.